
FYR Enters Know-How Agreement with Mayo Clinic to Collaborate on Blood-Based Biomarker Solutions for Parkinson’s Disease
MISSOULA, Mont., April 29, 2025 (GLOBE NEWSWIRE) -- FYR, a biotechnology company leveraging extracellular vesicles (EVs) to dynamically observe disease and treatment responses, today announced a collaboration with Mayo Clinic seeking to advance the use of …